CELLUMED Co (XKRX:049180) Retained Earnings : ₩-115,764 Mil (As of Sep. 2024)

View and export this data going back to 2002. Start your Free Trial

What is CELLUMED Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. CELLUMED Co's retained earnings for the quarter that ended in Sep. 2024 was ₩-115,764 Mil.

CELLUMED Co's quarterly retained earnings declined from Mar. 2024 (₩-111,106 Mil) to Jun. 2024 (₩-113,810 Mil) and declined from Jun. 2024 (₩-113,810 Mil) to Sep. 2024 (₩-115,764 Mil).

CELLUMED Co's annual retained earnings declined from Dec. 2021 (₩-66,523 Mil) to Dec. 2022 (₩-72,188 Mil) and declined from Dec. 2022 (₩-72,188 Mil) to Dec. 2023 (₩-109,477 Mil).

CELLUMED Co Retained Earnings Historical Data

The historical data trend for CELLUMED Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CELLUMED Co Retained Earnings Chart

CELLUMED Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Retained Earnings

Get a 7-Day Free Trial

-60,755.52

-61,582.90

-66,522.96

-72,187.63

-109,477.42

CELLUMED Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Retained Earnings	Get a 7-Day Free Trial															-84,851.98	-109,477.42	-111,105.96	-113,809.86	-115,764.07

CELLUMED Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

CELLUMED Co (XKRX:049180) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

CELLUMED Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CELLUMED Co Ltd (XKRX:049180) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

Acetechno Tower 9 402, Gasan-dong, Geumcheon-gu, Seoul, KOR, 153-782

Website

http://www.cellumed.co.kr

CELLUMED Co Ltd is a Korean company which is engaged in manufacturing and sale of medical equipment and biosimilars. Its products portfolio includes allografts for tissue repair, bone sponges, bone powders and demineralized bone matrixes (DBMs) for bone regeneration and biosimilars such as bone morphogenetic protein 2 (BMP2) reagents and others. It also produces medical devices, such as spinal fixation systems, joint replacements, and navigation systems.

CELLUMED Co Headlines

No Headlines